Our technology gives failed drug molecules a second chance.

Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology

PRESS RELEASE 19 September 2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology Helsinki, Finland – Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the …

Nanoform set to transform drug development through €7 million investment in patented nanoparticle technologyRead More »